Subscribe

EAPCI Column

DOI:

EAPCI Focus on the EAPCI Scientific Documents and Initiatives Committee

An interview with the Chair Giulio Stefanini

Figure 1

Figure 1.

What is the role of the committee?

Any proposal for scientific documents received by the EAPCI must be submitted to the Scientific Documents and Initiatives Committee (SDIC) for approval prior to their development. Together with my Co-Chair Nieves Gonzalo and committee members, the SDIC reviews all document proposals and makes approval or rejection recommendations. These recommendations are then reviewed and confirmed by the EAPCI Executive Committee. The responsibilities of the committee include the screening and validation of solicited and unsolicited documentation proposals as well as the identification of topics suitable for EAPCI scientific documents. Once the topic has been selected and approved, the committee is responsible for the administrative supervision and coordination of Writing Groups, coordination of the declarations of interest process for appointed authors as well as coordination of the review process.

How do EAPCI scientific documents benefit the community?

The key benefit of EAPCI scientific documents is to provide guidance for clinical management on topics not covered, or not covered in sufficient detail, in the existing or upcoming ESC Clinical Practice Guidelines. Whilst their topics and scope should not overlap with those of guidelines, scientific documents may complement them by providing more in-depth information in specific areas that cannot be expanded upon in guidelines. Our scientific documents evaluate scientific evidence, explore expert consensus in a structured way and, typically, include very practical advice for daily management of the topics discussed.

How are topics chosen and how can EAPCI members contribute?

Any EAPCI member may submit a proposal for a scientific document; any proposal received is subject to the robust and transparent review process of the SDIC followed by the EAPCI Executive Committee. Furthermore, one of the roles of the SDIC is to identify areas of unmet need and propose these topics to the EAPCI Executive Committee for consideration.

What are the upcoming topics?

  • Percutaneous coronary intervention in patients with cancer
  • Follow-up strategies in patients after transcatheter aortic valve replacement
  • Day-clinic care for percutaneous cardiovascular interventions
  • Sex-related considerations in mitral and tricuspid valve interventions

News

  • Attending ESC Congress 2023 in Amsterdam from August 25th-28th? Come to the ESC Plaza and find out more about EAPCI.
  • Not yet an EAPCI member? Join online https://www.escardio.org/EAPCI
Volume 19 Number 5
Aug 7, 2023
Volume 19 Number 5
View full issue

Suggested by Cory

Viewpoint

Feb 16, 2026
PCR: a new era dawns
Prendergast B
free

Editorial

10.4244/EIJ-D-25-01330 Feb 16, 2026
Aspirin discontinuation after ACS: timing the transition to ticagrelor monotherapy
Gragnano F and Calabrò P
free

Editorial

10.4244/EIJ-D-25-01331 Feb 16, 2026
Will the dream of "leave nothing behind" remain a utopia if we forget to optimise the systemic medical therapy?
Wykrzykowska J and Kraak R
free

State-of-the-Art

10.4244/EIJ-D-25-00598 Feb 16, 2026
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation
Oshima A et al
free

Original Research

10.4244/EIJ-D-25-00618 Feb 16, 2026
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial
Verheye S et al
open access

Flashlight

10.4244/EIJ-D-25-00431 Feb 16, 2026
A novel spacer for transcatheter treatment of tricuspid regurgitation
Barbieri F et al
open access
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
Can you provide a summary of the key findings in this article?
Can you extract and explain the primary hypothesis or research question addressed in this article?
What are the potential clinical applications or implications of the results presented in this paper?
How does this research contribute to our current understanding of cardiovascular disease management?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved